openPR Logo
Press release

Drug Eluting Balloon Catheters Market Is Anticipated To Progress At An Impressive CAGR Of 18% Through 2031 | Fact.MR Study

07-14-2022 05:30 AM CET | Health & Medicine

Press release from:

Drug Eluting Balloon Catheter Market Analysis by Indication (Coronary Artery Disease Drug Eluting Balloon Catheters, Peripheral Vascular Disease Drug Eluting Balloon Catheters), by End User (Hospitals, Ambulatory Surgical Centers), by Raw Material (Polyurethane Drug Eluting Balloon Catheters, Nylon Drug Eluting Balloon Catheters) & Regional Forecast, 2021-2031

The global market for drug eluting balloon catheters is anticipated to progress at an impressive CAGR of 18% over the next ten years. This analysis has been performed by skilled analysts at Fact.MR, a market research and competitive intelligence provider, also reveals that demand for drug eluting balloon catheters comprises 20% share in the overall balloon catheters market at present. As per the study, the global drug eluting balloon catheter market is expected to be worth US$ 5.2 Bn by the end of 2031, with coronary artery disease drug eluting balloon catherization holding a mammoth 80% market share.

To remain 'ahead' of your competitors, request a sample:

Prominent Key players of the Drug eluting balloon catheters market survey report:

Cardionovum GmbH
Cook Medical INC
Cordis Corporation
Abbott Laboratories
Meril Life Sciences Pvt Ltd
Jotech GmbH
MicroPort Scientific Corporation
Terumo Corporation
Boston Scientific Corporation
Speak To Research Analyst For Detailed Insights

MaKey Segments of Drug Eluting Balloon Catheter Industry Surveyrket Taxonomy
By Indication:
Coronary Artery Disease Drug Eluting Balloon Catheters
Peripheral Vascular Disease Drug Eluting Balloon Catheters
By End User:
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
By Raw Material:
Polyurethane Drug Eluting Balloon Catheters
Nylon Drug Eluting Balloon Catheters
The insights for each vendor consists of:

Company profile
SWOT analysis
Main market information
Market share
Revenue, pricing and gross margin
What insights does the Drug eluting balloon catheters Market report provide to the readers?

Drug eluting balloon catheters fragmentation on the basis of product type, end use, and region.
Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
Collaborations, R&D projects, acquisitions, and product launches of each Drug eluting balloon catheters player.
Various regulations imposed by the governments on the consumption of Drug eluting balloon catheters in detail.
Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global Drug eluting balloon catheters.
Full Access of this Report Is Available at

The report covers following Drug eluting balloon catheters Market insights and assessment that are helpful for all participants involved in the Drug eluting balloon catheters market:

Data on recently introduced regulations and their impact on key industries and on demand in Drug eluting balloon catheters
Latest industry Analysis on Drug eluting balloon catheters Market, with key analysis of market drivers, trends, and influencing factors
Key trends Analysis of Drug eluting balloon catheters Market and changing consumer preferences in major industries.
Changing Drug eluting balloon catheters demand and consumption of diverse products
Major trends underlining funding by key investors in numerous countries
New investment opportunities in diverse technology and product or service types
Comprehensive data and Competitive analysis of Drug eluting balloon catheters major players
Drug eluting balloon catheters Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
Drug eluting balloon catheters demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth
Questionnaire answered in the Drug eluting balloon catheters Market report include:

How the market for Drug eluting balloon catheters has grown?
What is the present and future outlook of the global Drug eluting balloon catheters on the basis of region?
What are the challenges and opportunities for the Drug eluting balloon catheters?
Why the consumption of Drug eluting balloon catheters highest in region?
In which year segment is expected to overtake segment?
Read Our Latest Article on Healthcare Domain

11140 Rockville Pike, Suite 400, Rockville, MD 20852, United States

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Catheters Market Is Anticipated To Progress At An Impressive CAGR Of 18% Through 2031 | Fact.MR Study here

News-ID: 2679556 • Views: 185

More Releases from

Global Niobium Hydride Market Is Forecast To Grow To US$ 67 Million By 2032
The global niobium hydride market reached a valuation of US$ 38 million at the end of 2021 and is forecast to grow to US$ 67 million by 2032, expanding at a high CAGR of 5.4%. Stronger downstream demand, rising consumer spending, and increased business investments are likely to benefit niobium hydride suppliers. Despite an economic slowdown, the global hydrogen industry is poised to witness significant growth over the coming years. Ramped-up production
Surging Sales of Cost-Effective UAVs Positively Driving Anti-Drone Market, Revea …
As per the latest market analysis by Fact.MR, a market research and competitive intelligence provider, the global anti-drone market is expected to reach a valuation of US$ 7.4 billion by the end of 2032 while expanding at an impressive CAGR of 20.9% over the assessment period. Drone neutralization equipment promises notable growth and a dynamic shift in the anti-drone market. Moreover, the emergence of cost-effective and open-source UAVs with new advanced
Integration of Smart Sensors to Support Vacuum Pump Market Growth in United Stat …
The United States vacuum pump market is estimated at US$ 1.8 billion in 2022, and is predicted to register impressive growth at 6.6% CAGR through 2032. The market registered yearly growth at 4.7% during 2017-2021, as per detailed analysis by Fact.MR, a market research and competitive intelligence provider. Manufacturers of vacuum pumps are launching systems with smart sensors that allow for the recording and saving of operating data. These kinds of innovations are
Epilator Consumption Across The World Is Anticipated To Increase At A CAGR Of 5. …
The global epilators market stands at US$ 406.8 million in 2022 and is estimated to reach a market valuation of US$ 695 million by the end of 2032. Worldwide consumption of epilators is predicted to increase at a CAGR of 5.5% between 2022 and 2032. As aesthetic awareness among people increases, it is expected to drive demand for hair removal devices, since having smooth hairless skin is aseptically pleasing as per

All 5 Releases

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug